This article provides a comprehensive comparison of chromogenic (DAB) and fluorescent detection methods in immunohistochemistry (IHC) and immunocytochemistry (ICC).
This comprehensive guide details the critical role of cell pellet preparation in generating robust controls for immunocytochemistry (ICC).
This comprehensive guide details the application of Clinical and Laboratory Standards Institute (CLSI) guidelines for the validation and verification of immunohistochemistry (IHC) assays within Clinical Laboratory Improvement Amendments (CLIA)-certified laboratories.
This article provides a comprehensive analysis of CLIA and FDA regulatory requirements for immunohistochemistry (IHC) assays, tailored for researchers, scientists, and drug development professionals.
This article provides a critical comparison between the Clinical Laboratory Improvement Amendments (CLIA) validation framework, predominant in the US, and the In Vitro Diagnostic Regulation (IVDR), the new EU regulatory...
This article provides a comprehensive, step-by-step framework for designing and executing a robust CLIA validation study for immunohistochemistry (IHC) assays.
This article provides a detailed roadmap for researchers and drug development professionals to successfully validate immunohistochemistry (IHC) predictive markers under Clinical Laboratory Improvement Amendments (CLIA) requirements.
This comprehensive guide demystifies the process of achieving CLIA (Clinical Laboratory Improvement Amendments) validation for Immunohistochemistry (IHC) assays.
This comprehensive guide addresses the critical need for validating immunohistochemistry (IHC) assays on alternative tissue fixatives under CLIA (Clinical Laboratory Improvement Amendments) regulations.
This comprehensive guide demystifies CLIA regulations for Immunohistochemistry (IHC) assay revalidation.